Alzheimer’s disease drug development pipeline: 2021

Cummings, Jeffrey, Lee, Garam, Zhong, Kate, Fonseca, Jorge, Taghva, Kazem·2021·Alzheimer's & Dementia: Translational Research & Clinical Interventions

DOI 10.1002/trc2.12179

Cited by (535)

Items 301–400 of 535

Microbiota–gut–brain axis and probiotics: potential therapeutic strategies for treating Alzheimer’s disease
Thekkuttuparambil Ananthanarayanan Ajith, Jagal Kishore Sreejith · 2025 · Nutritional Neuroscience
Design, synthesis, and biological evaluation of novel 2-acetylphenol-rivastigmine hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease
Cong Deng, Jing Mi, Yi Ming Zhou, Xinjuan Li, Zhengwei Liu, Zhipei Sang, Hui Li · 2022 · Medicinal Chemistry Research
Improvement of Cognitive Function by Fermented Panax ginseng C.A. Meyer Berries Extracts in an AF64A-Induced Memory Deficit Model
Eun‐Jung Yoon, Jeong Won Ahn, Hyun-Soo Kim, Yunseo Choi, Jiwon Jeong, Seong Soo Joo, Dongsun Park · 2023 · Nutrients
Toxicity Evaluation of Anti‐cholinesterasic Amphibian Extracts by MTT and an Optimized Artemia salina Test
Roque Spinelli, Álvaro Rietmann, Ivan Sanchís · 2023 · Chemistry & Biodiversity
Krankheitsmodifizierende Therapieansätze bei Alzheimer-Krankheit
Lutz Frölich, Lucrezia Hausner · 2021 · Der Nervenarzt
Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer’s Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling
Sze Chung Yuen, Simon Ming‐Yuen Lee, Siu-wai Leung · 2021 · Journal of Alzheimer s Disease
What contribution can genetics make to predict the risk of Alzheimer's disease?
Catherine Schramm, David Wallon, Gaël Nicolas, Camille Charbonnier · 2022 · Revue Neurologique
How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?
Kathy Y Liu, Madhav Thambisetty, Robert J. Howard · 2022 · Alzheimer s & Dementia
Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease
Justyna Godyń, Paula Zaręba, Dorota Stary et al. · 2022 · Molecules
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
Ilse Bader, Ilona Bader, Isadora Lopes Alves, David Vállez García, Bruno J. Vellas, Bruno Dubois, Merçé Boada, Marta Marquié, Daniele Altomare, Philip Scheltens et al. · 2023 · Alzheimer s Research & Therapy
Aggregation Condition–Structure Relationship of Mouse Prion Protein Fibrils
Jēkabs Fridmanis, Zigmantas Toleikis, Tomas Šneideris · 2021 · International Journal of Molecular Sciences
Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine
Qiang Chen, Guanghui Chen, Qianyan Wang · 2025 · Planta Medica
Humanized rodent models of neurodegenerative diseases and other brain disorders
Xinru Zhang, Jianxiang Wang, Jiewen Zhang, Chao Jiang, Xuezhong Liu, Shuaijiang Wang, Zhenhua Zhang, Yousef Rastegar‐Kashkooli, Fatemeh Dialameh, Qinfeng Peng et al. · 2025 · Neuroscience & Biobehavioral Reviews
Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases
Alex Foster‐Powell, Amin Rostami‐Hodjegan, Guy M. L. Meno‐Tetang, Donald E. Mager, Kayode Ogungbenro · 2025 · CPT Pharmacometrics & Systems Pharmacology
Kynurenine pathway: a possible new mechanism for exercise in the prevention and treatment of Alzheimer's disease
Gangqiang Li, Shuang Li, Wenhui Zhou · 2025 · Frontiers in Aging Neuroscience
Guidelines for the use and interpretation of Alzheimer’s disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Adalberto Studart‐Neto, Breno José Alencar Pires Barbosa, Artur Martins Coutinho, Leonardo Cruz de Souza, Lucas Porcello Schilling, Mari Nilva Maia da Silva, Raphael Machado Castilhos, Paulo Henrique Ferreira Bertolucci, Wyllians Vendramini Borelli, Hélio Rodrigues Gomes et al. · 2024 · Dementia & Neuropsychologia
The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease
Timothy P Daly, Stéphane Epelbaum · 2022 · AJOB Neuroscience
Recent advances in nanotechnology for combating Alzheimer's disease
Chuan Hu, Baoyu Wu, Yihan Wu, Mingyi Shi, Jiaqi Ma, Huile Gao, Jinming Zhang · 2023 · Materials Chemistry Frontiers
Novel (p-tolyl)-3(2H)-pyridazinone derivatives containing substituted-1,2,3-triazole moiety as new anti-Alzheimer agents: Synthesis, in vitro and in silico assays
İrem Bozbey Merde, Gülce Taşkor Önel, Burçin Türkmenoğlu · 2022 · Fabad Journal of Pharmaceutical Sciences
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
João Pedro Ferrari‐Souza, Pâmela C.L. Ferreira, Bruna Bellaver, Cécile Tissot, Yi-Ting Wang, Douglas Teixeira Leffa, Wagner Scheeren Brum, Andréa Lessa Benedet, Nicholas James Ashton, Marco Antônio De Bastiani et al. · 2022 · medRxiv
Tracing Alzheimer’s Genetic Footprints: A Pioneering Longitudinal Study Using Artificial Intelligence to Unravel Mutation- Driven Risks and Progression in Virtual Patients; Part 1 – The APOE genotypes
Wayne R. Danter · 2024 · medRxiv
The Oral–Gut–Brain Axis: From Periodontal Dysbiosis to Neuroinflammation—Mechanistic Pathways, Salivary and Intestinal Biomarkers, and Therapeutic Targets: A Narrative Review
Dumitru, Caterina Nela, Dumitru, Alina Oana, Popa, Gabriel Valeriu, Marcu, Teodora, Ursu, Maria, Nechita, Aurel, Matei, Nicoleta Madalina · 2026 · Dentistry Journal
Neural mechanisms of non-pharmacological interventions in patients with mild cognitive impairment and Alzheimer's disease: An ALE meta-analysis
Ning Wang, Jinkun Li, Yunxiao Guo, Panbing Zhang, Fulin You, Ziyi Wang, Zhonghuan Wang, Xiaobin Hong · 2025 · Experimental Gerontology
Transcriptomic and network analysis identifies shared pathways across Alzheimer’s disease and vascular dementia
Cengceng Zheng, Yejing Zhao, Chaoying Hu, Li Zhang, G Y Li, Cuicui Yang · 2025 · Brain Research
Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer’s disease
A. Meden, Neža Žnidaršič, Damijan Knez, Yuanyuan Wang, Ziwei Xu, Huajing Yang, Weiting Zhang, Anja Hafner Pišlar, Andrej Perdih, Simona Kranjc et al. · 2025 · Acta Pharmaceutica Sinica B
Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation
Marta Matuszewska, Anna Wilkaniec, Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Gabriela Olech-Kochańczyk, Ewelina Pałasz, Elżbieta Gawinek, Marcin Strawski, Grzegorz Arkadiusz Czapski · 2025 · Frontiers in Molecular Neuroscience
Regression analysis of topological indices for predicting efficacy of Alzheimer’s drugs
Tahreem Ashraf, Nazeran Idrees, Melaku Berhe Belay · 2024 · PLoS ONE
Design and synthesis three novel series of derivatives using natural acetylcholinesterase inhibitor-RLMS as template and in vitro, in vivo and in silico activities verification
Fang He, Yongdan Guo, Xin Shen · 2025 · European Journal of Medicinal Chemistry
Primary Progressive Aphasias: Diagnosis and Treatment
Genaro Gabriel Ortíz, Héctor González-Usigli, Erick René Nava-Escobar, Luis Javier Ramírez-Jirano, Mario Alberto Mireles-Ramírez, Maribel Orozco-Barajas, Luis Eduardo Becerra-Solano, Víctor Sánchez-González · 2025 · Brain Sciences
Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
Krista L. Lanctôt, Linus Jönsson, Alireza Atri, Russ Paulsen, Soeren Mattke, Julie Hviid Hahn‐Pedersen, Pepa Polavieja, Thomas Maltesen, Teresa León, Anders Gustavsson et al. · 2025 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer’s drug discovery: Promising futuristic structural designs
Atukuri Dorababu · 2025 · Journal of Pharmacology and Experimental Therapeutics
Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer’s Disease
Joanna Batko, Katarzyna Antosz, Hanna Nowakowska, Marta Błażejewska, Eunika Milena Kowalik, Jan Aleksander Beszłej, Jerzy Leszek · 2025 · International Journal of Molecular Sciences
Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I2 Receptor Ligand B06
Andrea Bagán, Jose Angel Morales-Garcia, Christian Griñán‐Ferré et al. · 2022 · International Journal of Molecular Sciences
Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models
Jakub P. Hlávka, Bryan Tysinger, Jeffrey C. Yu, Darius Noshir Lakdawalla · 2022 · Value in Health
A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment**
Shi Kuang, Biyue Zhu, Jing Zhang, Fan Yang, Bo Wu, Weihua Ding, Liuyue Yang, Shiqian Shen, Seven H. Liang, Prasenjit Mondal et al. · 2023 · Angewandte Chemie
Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects
Francisco Martínez‐Dubarbie, Sara López‐García, Carmen Lage, Guglielmo Di Molfetta, Marta Fernández‐Matarrubia, Ana Pozueta‐Cantudo, María García‐Martínez, Andrea Corrales‐Pardo, María Bravo, Julio Francisco Jiménez-Bonilla et al. · 2024 · Journal of Alzheimer s Disease
Blood biomarkers as surrogate endpoints in Alzheimer’s disease research
Guogen Shan, Hui Li, Yahui Zhang, Guoqiao Wang, Charles B. Bernick · 2025 · Frontiers in Aging Neuroscience
Roadmap for ecosystem-based approach for patients with Alzheimer disease in Russia: current needs, barriers, and possible solutions (resolution of the scientific and practical experts meeting)
Anna Nicolaevna Bogolepova, E V Brovko, Gavrilova Si et al. · 2022 · S S Korsakov Journal of Neurology and Psychiatry
Design, synthesis and evaluation of salicylic acid-donepezil hybrids as functional agents for the treatment of Alzheimer’s disease
Ying He, Zhili Rao, Zhengwei Liu et al. · 2023 · Medicinal Chemistry Research
Re‐remembering the influence of randomized β‐carotene on cognitive decline
Rachel E. Kopec, Daniel I. Chasman, Olivia I. Okereke, Howard D. Sesso · 2023 · Alzheimer s & Dementia
PLGA mediated drug delivery for Alzheimer's disease
Tosha Pandya, Mangesh Kulkarni, Sheetal Porecha Acharya, Bhupendra Gopalbhai Prajapati · 2024 · Elsevier eBooks
Coupled Neural–Glial Dynamics and the Role of Astrocytes in Alzheimer’s Disease
Swadesh Pal, Roderick Melnik · 2022 · Mathematical and Computational Applications
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?
John Baker, Jonathan M. Schott · 2022 · Revue Neurologique
Automated brain image analysis in dementia using artificial intelligence: a roadmap for the development of clinical tools
Ashwin V. Venkataraman, Charles R. Marshall, Timothy Rittman · 2023
Focus on Neurochemistry Led to the Cholinergic Hypothesis of Alzheimer’s Disease
Christian Behl · 2023 · Springer eBooks
The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro
Marta Matuszewska, Anna Wilkaniec, Magdalena Cieślik, Marcin Strawski, Grzegorz Arkadiusz Czapski · 2025 · Biomolecules
Euphorbia diterpenoids from Euphorbia peplus possessing anti-Alzheimer's activity via targeting PPARγ and upregulating the level of ABCA1
Yanlan Yang, Shoulun He, Ying‐Ting Lin, Junjie Chen, Renjing Yang, Xueli Li, Jingyu Sun, Guanghui Wang, Wenjing Tian, Haifeng Chen · 2025 · Phytochemistry
In silico exploration of cholinergic activity and neuroprotection of novel caffeine analogues
Diego Javier Obiol, Agustín Vietri, Juan Pablo Munafó, Marcelo D. Costabel, Silvia S. Antollini · 2025 · Biochemical and Biophysical Research Communications
Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment
Constantine George Lyketsos, Seth Roberts, Elaine K. Swift et al. · 2022 · The Journal of Prevention of Alzheimer s Disease
The dawn of disease modification for Alzheimer's disease: Hope and peril
Zaldy Sy Tan · 2022 · Journal of the American Geriatrics Society
Decision making under uncertainty in the diagnosis and management of Alzheimer's Disease in primary care: A study protocol applying concepts from neuroeconomics
Gustavo Saposnik, Zahinoor Ismail, Anne-Marie Rivard, Debbie Knifton, Gillian P. Bromfield, María Terzaghi, Alonso G. Montoya, Marie‐Chantal Ménard · 2022 · Frontiers in Medicine
Conformation-Specific Association of Prion Protein Amyloid Aggregates with Tau Protein Monomers
Mantas Žiaunys, Kamilė Mikalauskaitė, Lukas Krasauskas, Vytautas Smirnovas · 2023 · International Journal of Molecular Sciences
Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance
Divya Adiga, Sangavi Eswaran, S. Sriharikrishnaa, Nadeem Ghani Khan, Dileep Kumar, Shama Prasada Kabekkodu · 2024 · Current Topics in Medicinal Chemistry
Recent Molecular Targets and their Ligands for the Treatment of Alzheimer Disease
Gülşah Bayraktar, Vildan Alptüzün · 2024 · Current Topics in Medicinal Chemistry
Transformative Potential IoT Sensor Frameworks for Real-Time Alzheimer's Detection and Monitoring in Elderly Populations
Kamlesh Mani, Kamlesh Kumar Singh, Ratnesh Litoriya · 2024
Therapeutic Opportunities for Food Supplements in Neurodegenerative Diseases
Andrea D. Praticò · 2025 · Nutrients
Neuroprotective functions of the APPI domain of amyloid precursor protein (APP): Reducing KLK6-mediated APP cleavage and Aβ42 formation and aggregation
Shiran Lacham‐Hartman, Ofek Oren, Maya Rabinovitch, Niv Papo · 2025 · International Journal of Biological Macromolecules
Die Nationale Demenzstrategie
Frank Jessen · 2022 · Fortschritte der Neurologie · Psychiatrie
Identification of CNS compatible small molecules as glycogen synthase kinase-3β (GSK-3β) inhibitors through structure-based virtual screening
Sukanya Sukanya, Bhanwar Singh Choudhary, Pakhuri Mehta · 2022 · Medicinal Chemistry Research
Recent Treatment Strategies in Alzheimer's Disease and Chronic Traumatic Encephalopathy
Brandon Peter Lucke-Wold · 2022 · Biomedical Research and Clinical Reviews
Combinatorial therapy in Alzheimer's disease
Mahendra Ashok Giri, Prakash N. Kendre, R. D. Bhalke, Vishal Vijay Pande, Kalyani Appasaheb Autade, Rajashri Balasaheb Sumbe · 2024 · Elsevier eBooks
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
Haiyan Liu, Jonathan C. Li, Ellen Ziegemeier, S. Adams, Eric McDade, David B. Clifford, Yuping Cao, Guoping Wang, Y. Li, Susan L. Mills et al. · 2024 · The Journal of Prevention of Alzheimer s Disease
Altered central and blood glutathione in Alzheimer Disease and Mild Cognitive Impairment: a meta-analysis
Jinghan J Chen, Mathura T. Thiyagarajah, Jianmeng Song, Clara C. Chen, Nathan Herrmann, Damien Gallagher, Mark Jeffrey Rapoport, Sandra E. Black, Joel Ramirez, Ana C. Andreazza et al. · 2021 · Research Square
Next-Gen AI for Disease Definition, Patient Stratification, and Placebo Effect
Mike J. Tsay, Joseph Geraci, Abhishek Agrawal · 2020
A novel phosphodiesterase 4/5 dual-target inhibitor ameliorates neuroinflammation via the NF-κB and JNK pathway
Liyun Zhao, Wenjie Jiang, Yingying Cao, Yi‐You Huang, Xue Wang, Li Guo, Dongke Yu, Jianyou Shi · 2025 · International Journal of Biological Macromolecules
Pathological Disulfide Bond Crosslinking: Molecular Insights into Amyloidogenesis and Diseases Progression
Dong Min Kang, Nataliia Lukianenko, Ja‐Hyun Baik, Yun Kyung Kim, Sungsu Lim · 2025 · ChemBioChem
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
Neevashini Chengebroyen, Anmol Seelan, Kamal Y. Thajudeen, Saad Ali Alshehri, Aritra Biswas, Israrahmed Adur, Vino Sundararajan, Sajitha Lulu Sudhakaran, Harpreet Singh · 2025 · Frontiers in Pharmacology
Neuroprotective potential of green-synthesized silver nanoparticles from Psidium guajava in a scopolamine-induced rat model of Alzheimer's disease
Adesh Tagad, Sunil T. Galatage, Nanjappaiah Hankuntimath · 2025 · Annales Pharmaceutiques Françaises
Nanomaterials: an overview of current trends and future prospects in neurological disorder treatment
Deboral Eshak, Mohanapriya Arumugam · 2025 · Journal of Translational Medicine
Research progress on 40 Hz sensory stimulation for the treatment of Alzheimer’s disease
Bing Tang, Ming Tao · 2026 · Frontiers in Aging Neuroscience
Targeting Lipid Metabolism in Alzheimer’s Disease: Emerging Insights and Future Directions
Jeyakumar Balakrishnan, Suganya Kannan, Kathiresan Shanmugam, Sugasini Dhavamani · 2026 · Journal of Integrative Neuroscience
Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases
Ana K. Villagómez‐Guzmán, Israel Valencia Quiroz · 2024 · Recent advances in biotechnology
Unveiling metabolic patterns in dementia: Insights from high‐resolution quantitative blood‐oxygenation‐level‐dependent MRI
Arun Raj T., Karthik Kulanthaivelu, Joseph Suresh Paul · 2024 · Medical Physics
Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An Update
Kratika Pandey, Priyanka Srivastava, Swaroop Kumar Pandey, Surabhi Johari, Priyanka Bhatnagar, Madhavi Sonane, Anuja Mishra · 2024 · Current Molecular Medicine
PLB2Tau mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI
Jacques Micheau, Gwénaëlle Catheline, Elodie Barse, Bassem Hiba, Anne Marcilhac, Michèle Allard A, Bettina Platt, Gernot Riedel · 2024 · Brain Research Bulletin
Recent Updates on Alzheimer’s Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease
Arun Kumar Mishra, Alankar Srivastava, Varsha Raj, Vipin Saini, Gyas Khan, Harpreet Singh, Amrita Mishra, Sarvesh Paliwal · 2024 · Current Alzheimer Research
Reevaluating Alzheimer’s disease treatment: Can phytochemicals bridge the therapeutic Gap?
Kishor Kumar Roy, Dinesh Kumar Mehta, Rina Das · 2025 · Neuroscience
Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies
Sunny Rathee, Vishal Pandey, Sakshi Soni, Debasis Sen, Sanjay Jain · 2025 · Current Alzheimer Research
Influence of Cortisol on the Fibril Formation Kinetics of Aβ42 Peptide: A Multi-Technical Approach
A. Nucara, Francesca Ripanti, Simona Sennato, Giacomo Nisini, Emiliano De Santis, Mahta Sefat, Marina Carbonaro, Dalila Mango, Velia Minicozzi, Marilena Carbone · 2022 · International Journal of Molecular Sciences
Progression from Prodromal Alzheimer’s Disease to Mild Alzheimer’s Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions
Tiffini Voss, James T. Kost, Swati P. Mercer, Christine I. Furtek, CHRISTOPHER C. RANDOLPH, Christopher Lines, Michael F. Egan, Jeffrey L. Cummings · 2023 · Journal of Alzheimer s Disease
Subcellular proteomics insights into Alzheimer's disease development
Zhiyuan Liang, Hongbin Zhuang, Xueshan Cao, Guanwei Ma, Liming Shen · 2023 · PROTEOMICS - CLINICAL APPLICATIONS
Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis
Галанкин Тимофей Леонидович, Anton Bespalov, Hans Y. Moebius · 2024 · Journal of Alzheimer s Disease
Time perception among people living with and without dementia: A scoping review
Natasha L. Gallant, Chelsea L Russill, Natasha C Taylor, Sarah Nakonechny, Amara Kohlert, Kyley Ewing · 2024 · Dementia
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia A. Martínez-Iglesias, Natalia Cacabelos, Jairo Carrera, Daniel Rodríguez, Vinogran Naidoo · 2025 · Expert Opinion on Drug Metabolism & Toxicology
Targeting the immune system towards novel therapeutic avenues to fight brain aging and neurodegeneration
Javier María Peralta Ramos, Denise Kviatcovsky, Michal Schwartz · 2022 · European Journal of Neuroscience
Positive opinion of the French National Authority for Health on the reimbursement of amyloid tracer (Flutemetamol)
Antoine Garnier‐Crussard, Anthime Flaus · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects
Sakshi Rai, Amritha Nair, Zirha Saleem, Suman Kumar Ray, Jagat R. Kanwar, Sukhes Mukherjee · 2025 · Neuroscience
Stress, Stress Management, and Dementia: A Narrative Review
Arunima Chaudhuri, Dharmendra K Gupta · 2025 · Cureus
A REVIEW OF FLUORESCEIN ANGIOGRAPHY, INDOCYANINE GREEN ANGIOGRAPHY, AND OTHER FLUOROPHORES IN OPHTHALMOLOGY
Alexis Kaiser, José S. Pulido, Alexander J. Brucker, Yoshihiro Yonekawa, Nikhil K. Bommakanti · 2025 · Retina
Brain Gamma-Stimulation: Mechanisms and Optimization of Impact
Konstantin V. Lushnikov, Dmitriy A. Serov, Maxim E. Astashev, В. А. Козлов, Alexander Melerzanov, Maria V. Vedunova · 2025 · Biology
Engineering nanobodies for drug delivery systems in Alzheimer’s disease
Thee Jootar, Suradej Hongeng, Wararat Chiangjong · 2026 · Artificial Cells Nanomedicine and Biotechnology
Multimodal fusion network with multi-scale structure and metabolic focus for enhancing Alzheimer’s disease prediction
Jiayuan Cheng, Fei Liu, Shicheng Wei · 2026 · Applied Intelligence
Bridging the computational-experimental gap: leveraging large language model to prioritize Alzheimer’s therapeutics based on comparison of learning models
Manqi Li, Shuteng Niu, Y. Xu, Jianfu Li, Xinyue Hu, Duan Liu, Merve Atık, Xiaolei Xu, Liewei Wang, Nilufer Ertekin-Taner et al. · 2026 · npj Health Systems
Exercise Interventions for Cognitive and Functional Outcomes in Dementia: A Systematic Review and Meta-Analysis Exploring Dose Metrics, Heterogeneity, and Implementation-Relevant Factors
Chun-Wei Lu, Tsz-Ching Ng, Yi-Chen Cheng, Chun-Hsien Su · 2026 · Healthcare
Estimated Wasteful Spending on Aducanumab Dispensing in the U.S. Medicare Population: A Cross-Sectional Analysis
C. Oronce, J. Arbanas, M. Leng, B. Landon, C. Damberg, C. Sarkisian, J. Mafi · 2022 · Journal of The American Geriatrics Society
Natural products in neuroprotective therapies: Experimental and cheminformatics approaches to manage neurological disorders
Md. Mominur Rahman, Md. Abid Hossain, Kajima Rifat, Saila Kabir Maeesa, A. M. Abu Sayem Rahman, Mahamuda Akter Mim, Nasrin Sultana, Dipongkar Ray Sobuj, Israt Jahan Tamanna, Md. Rezaul Islam et al. · 2024 · Applied Chemical Engineering
ADVANCEMENT IN THE TREATMENT OF ALZHEIMER'S DISEASE, 2023
Anum Safdar, Muhammad Usman Ghani, Muhammad Farooq Sabar, Muhammad Umer Khan, Mureed Hussain, Khuram aziz, Taha Hussain · 2024 · International Journal of Pharmacy & Integrated Health Sciences
Ameliorative potential of ethanol extract of Calyptrochilum emarginatum leaves on scopolamine-induced amnesia in male swiss mice
Stella Afolakemi Adeyemo, Mutiu Yombo Ajao, Kehinde Joshua Ogundeyi, Omowunmi Femi-Akinlosotu, Adewale Ganiyu Bakre · 2024 · Journal of Ethnopharmacology
Alzheimer’s Disease: Epidemiology, Etiology, Risk Factors, and Future Predictions
Gifty M. Jojo, Jobin Johnson, Gowthamarajan Kuppusamy, Veera Venkata Satyanarayana Reddy Karri · 2024 · Springer eBooks
A novel method for harmonization of PET image spatial resolution without phantoms
Félix Carbonell, Alex P. Zijdenbos, Evan Hempel, Mihály Hajós, Barry J. Bedell, Alzheimer’s Disease Neuroimaging Initiative · 2025 · EJNMMI Physics